Dr. Tiago Reis Marques

CEO
Pasithea Therapeutics Corp.
(NASDAQ: KTTA)

Dr. Marques is a fellow at Imperial College London and a lecturer at the Institute of Psychiatry, King’s College London. Dr. Marques is also a psychiatrist at Maudsley Hospital, rated as one of the top three psychiatry centres in the world. His research focuses on topics including the mechanism of action of psychiatric medication and the unveil of novel treatment targets. Dr. Marques has received numerous prestigious awards for his research and published hundreds of scientific papers including international treatment guidelines.